BetterLife Pharma (BETRF) Net Income - Minority (2022 - 2026)

BetterLife Pharma's Net Income - Minority history runs 5 years deep, the most recent figure standing at $2454.8 for Q2 2026.

• In Q2 2026, Net Income - Minority rose 179.39% year-over-year to $2454.8; the TTM figure through Apr 2026 stood at $2454.8 (up 179.39% YoY), while the FY2023 annual figure was $272858.5, changed N/A from the prior year.
• Net Income - Minority for Q2 2026 stood at $2454.8, down from $7012.2 in the prior quarter.
• The five-year high for Net Income - Minority was $456429.1 in Q4 2023, with the low at -$3092.0 in Q2 2025.
• The 5-year median for Net Income - Minority is $78521.1 (2024), against an average of $177580.3.
• The sharpest annual moves came in 2023 and 2025: Net Income - Minority jumped 25459.83% in 2023, then plunged 104.09% in 2025.
• BetterLife Pharma's Net Income - Minority stood at $305998.5 in 2022, then jumped by 49.16% to $456429.1 in 2023, then plunged by 88.74% to $51412.5 in 2024, then slumped by 86.36% to $7012.2 in 2025, then slumped by 64.99% to $2454.8 in 2026.
• Business Quant data shows BETRF's Net Income - Minority at $2454.8 in Q2 2026, $7012.2 in Q3 2025, and -$3092.0 in Q2 2025.